Department of Surgery and The Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Dis Colon Rectum. 2012 Mar;55(3):351-8. doi: 10.1097/DCR.0b013e318239d1e4.
The management of fistula-in-ano is a balance between fistula cure and preservation of continence.
The aim of this study is to summarize the anal fistula plug literature for Crohn's and non-Crohn's fistula-in-ano in a homogenous patient population.
PubMed, MEDLINE, Embase, and Cochrane medical databases were searched from 1995 to 2011. Abstracts from The American Society of Colon and Rectal Surgeons, The Society for Surgery of the Alimentary Tract, The European Society of Coloproctology, and the Association of Coloproctology of Great Britain and Ireland meetings between 2007 and 2010 were also evaluated.
Studies were included if results for patients with and without Crohn's disease could be differentiated. Patients with rectovaginal, anovaginal, rectourethral, or ileal-pouch vaginal fistulas were excluded as were studies where the mean or median follow-up was less than 3 months. Two researchers independently selected studies matching the inclusion criteria.
Anal fistula plug insertion was performed.
The primary outcomes measured were the overall fistula closure rates and length of follow-up.
Seventy-six articles or abstracts were identified from the title as being of relevance. Twenty studies (2 abstracts, 18 articles) were finally included. Study sample size ranged from 4 to 60 patients; 530 patients were included in all studies (488 non-Crohn's and 42 Crohn's patients). The plug extrusion rate was 8.7% (46 patients). The proportion of patients achieving fistula closure varied widely between studies for non-Crohn's, ranging from 0.2 (95% CI 0.04-0.48) to 0.86 (95% CI 0.64-0.97). The pooled proportion of patients achieving fistula closure in patients with non-Crohn's fistula-in-ano was 0.54 (95% CI 0.50-0.59). The proportion achieving closure in patients with Crohn's disease was similar (0.55, 95% CI 0.39-0.70).
This study was limited by the variability of operative technique and perioperative care between studies.
Fistula closure is achieved by using the anal fistula plug in approximately 54% of patients without Crohn's disease. The anal fistula plug has not been adequately evaluated in the Crohn's population.
肛瘘的治疗是在治愈瘘管和保护肛门功能之间的平衡。
本研究旨在总结克罗恩病和非克罗恩病肛瘘患者中使用肛门瘘管栓的文献。
从 1995 年至 2011 年,检索了 PubMed、MEDLINE、Embase 和 Cochrane 医学数据库。还评估了 2007 年至 2010 年美国结肠直肠外科学会、消化道外科学会、欧洲结直肠外科学会和大不列颠及爱尔兰结直肠外科学会会议的摘要。
如果能区分克罗恩病患者和非克罗恩病患者的结果,则纳入研究。排除直肠阴道瘘、肛管阴道瘘、直肠尿道瘘或回肠袋阴道瘘患者,以及平均或中位数随访时间少于 3 个月的研究。两名研究人员独立选择符合纳入标准的研究。
进行肛门瘘管栓插入术。
主要观察指标是总体瘘管闭合率和随访时间。
从标题中确定了 76 篇文章或摘要作为相关内容。最终纳入了 20 项研究(2 篇摘要,18 篇文章)。研究样本量从 4 例到 60 例不等;共有 530 例患者纳入所有研究(488 例非克罗恩病患者和 42 例克罗恩病患者)。栓子脱出率为 8.7%(46 例)。非克罗恩病患者的瘘管闭合率在不同研究之间差异很大,范围为 0.2(95%置信区间 0.04-0.48)至 0.86(95%置信区间 0.64-0.97)。非克罗恩病肛瘘患者的总体瘘管闭合率为 0.54(95%置信区间 0.50-0.59)。克罗恩病患者的闭合率相似(0.55,95%置信区间 0.39-0.70)。
本研究受研究间手术技术和围手术期护理差异的限制。
在非克罗恩病患者中,使用肛门瘘管栓约可达到 54%的瘘管闭合率。肛门瘘管栓在克罗恩病患者中尚未得到充分评估。